• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Introduction: Apolipoproteins and guidelines for prevention of cardiovascular disease.

作者信息

Faergeman O

机构信息

Cardiovascular Medicine, National Heart and Lung Institute, Charing Cross Campus, Imperial College, London, UK.

出版信息

J Intern Med. 2006 May;259(5):434-6. doi: 10.1111/j.1365-2796.2006.01650.x.

DOI:10.1111/j.1365-2796.2006.01650.x
PMID:16629848
Abstract
摘要

相似文献

1
Introduction: Apolipoproteins and guidelines for prevention of cardiovascular disease.引言：载脂蛋白与心血管疾病预防指南
J Intern Med. 2006 May;259(5):434-6. doi: 10.1111/j.1365-2796.2006.01650.x.
2
Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I--new risk factors and targets for therapy.是否存在比低密度脂蛋白胆固醇更好的心血管风险标志物？载脂蛋白B和A-I——新的风险因素及治疗靶点。
Nutr Metab Cardiovasc Dis. 2007 Oct;17(8):565-71. doi: 10.1016/j.numecd.2007.02.010. Epub 2007 Jul 16.
3
[Determination of apolipoproteins: An important tool for prevention and treatment of cardiovascular diseases].
Lakartidningen. 2007;104(20-21):1623-4.
4
[Semiologic value of LDL cholesterol and apolipoprotein B in risk of atherosclerosis].
Ann Biol Clin (Paris). 1998 Sep-Oct;56(5):517-20.
5
Apolipoproteins as markers and managers of coronary risk.载脂蛋白作为冠状动脉风险的标志物和调控因子。
QJM. 2006 May;99(5):277-87. doi: 10.1093/qjmed/hcl027. Epub 2006 Feb 27.
6
Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk.载脂蛋白 B、非高密度脂蛋白胆固醇和 LDL 胆固醇可用于识别心血管风险增加的个体。
J Intern Med. 2010 Dec;268(6):567-77. doi: 10.1111/j.1365-2796.2010.02277.x.
7
Which lipid measures are prognostic indicators of cardiovascular disease in women?
Nat Clin Pract Endocrinol Metab. 2006 Apr;2(4):190-1. doi: 10.1038/ncpendmet0118.
8
Apolipoproteins AI and B as therapeutic targets.载脂蛋白AI和B作为治疗靶点。
J Intern Med. 2006 May;259(5):462-72. doi: 10.1111/j.1365-2796.2006.01646.x.
9
Homocysteine increases the risk associated with hyperlipidaemia.同型半胱氨酸会增加与高脂血症相关的风险。
Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):150-5. doi: 10.1097/HJR.0b013e32831e1185.
10
[Comparison of LDL-cholesterol results calculated by using apolipoproteins A1, B or HDL-cholesterol for classification of non-chylomicron dyslipidemias].
Ann Biol Clin (Paris). 1999 May;57(3):345-50.

引用本文的文献

1
Emerging Biomarkers and Determinants of Lipoprotein Profiles to Predict CVD Risk: Implications for Precision Nutrition.用于预测心血管疾病风险的脂蛋白谱的新兴生物标志物和决定因素：对精准营养的启示。
Nutrients. 2024 Dec 27;17(1):42. doi: 10.3390/nu17010042.
2
The relation between ApoB/ApoA-1 ratio and the severity of coronary artery disease in patients with acute coronary syndrome.急性冠状动脉综合征患者载脂蛋白B/载脂蛋白A-1比值与冠状动脉疾病严重程度的关系。
Egypt Heart J. 2021 Mar 16;73(1):24. doi: 10.1186/s43044-021-00150-z.
3
The association between the apolipoprotein B/A-I ratio and coronary calcification may differ depending on kidney function in a healthy population.
在健康人群中，载脂蛋白B/A-I比值与冠状动脉钙化之间的关联可能因肾功能而异。
PLoS One. 2017 Sep 28;12(9):e0185522. doi: 10.1371/journal.pone.0185522. eCollection 2017.
4
Predictive value of serum apolipoprotein B/apolipoprotein A-I ratio in metabolic syndrome risk: a Chinese cohort study.血清载脂蛋白B/载脂蛋白A-I比值对代谢综合征风险的预测价值：一项中国队列研究
Endocrine. 2015 Jun;49(2):404-14. doi: 10.1007/s12020-014-0447-z. Epub 2014 Oct 12.
5
ApoB/apoA1 is an effective predictor of coronary heart disease risk in overweight and obesity.载脂蛋白B/载脂蛋白A1是超重和肥胖人群冠心病风险的有效预测指标。
J Biomed Res. 2011 Jul;25(4):266-73. doi: 10.1016/S1674-8301(11)60036-5.
6
New Zealand cardiovascular guidelines: best practice evidence-based guideline: the assessment and management of cardiovascular risk December 2003.新西兰心血管指南：最佳实践循证指南：心血管风险评估与管理，2003年12月
Clin Biochem Rev. 2007 Feb;28(1):19-29.